1 November 2018 in Radiography
1 November 2018 in Radiography
11 August 2022 in Canadian Association of Radiologists Journal
Purpose: Bursitis is a common musculoskeletal cause of shoulder pain and treatment varies, thus correctly diagnosing and grading bursitis is paramount in deciding management. Our aim was to assess reliability in grading shoulder bursitis on ultrasonography among fellowship trained musculoskeletal radiologists at our institution. Methods: Retrospective study of patients diagnosed with bursitis on ultrasonography. Single-sonographic images of the subacromial-subdeltoid bursa were collected for each patient and randomized to form a test-bank of varying degrees of bursitis. Three months after the test was administered, the cases were randomized and readministered. The radiologists graded each case as: within normal limits, mild, moderate or severe. Intraobserver variability was measured using Cohen’s kappa coefficient. Linear regression model was performed to assess correlation between years of experience and kappa. Results: 10 radiologists reviewed 70 cases of bursitis. Kappa values ranged from .53 to .91, indicating ‘moderate’ to ‘almost perfect’ variability amongst radiologists. A moderate positive correlation of improving variability ( r = .69) with increasing years of experience exists. Conclusion: Fellowship trained musculoskeletal radiologists were able to grade shoulder bursitis with moderate to almost perfect variability, with a positive correlation of improved variability with increasing experience. This may help clinicians choose the correct treatment more confidently in their patients with shoulder pain.
1 January 2022 in JBJS Case Connector
Case: The global reach of coronavirus disease 2019 has led to the rollout of new generation messenger ribonucleic acid (mRNA) vaccines. As populations are vaccinated, some side effects will become more apparent. We present a case of unilateral lymphadenopathy resulting in a transient plexopathy presenting as neuralgic pain, paresthesia, and numbness in the hand. Conclusion: Multiple image modalities and electrodiagnostic studies were used to infer the diagnosis. This condition was expectantly managed, and the patient’s symptoms resolved within weeks.
7 September 2021 in Research Square
Background: Lung cancer is one of the leading causes of cancer-related mortality worldwide. Its poor prognosis is associated with late detection and high recurrence rates. We aimed to determine if certain imaging characteristics of lung cancer recurrence were predictors of extra-pulmonary metastatic disease.Methods: We conducted a retrospective study of all patients at our institution with lung cancer recurrence detected on post-treatment imaging between January 2014-October 2019. Research ethics board approval was obtained. Included patients underwent pre-treatment imaging, surgical resection, and post-treatment imaging. Imaging characteristics and pathological findings of the pulmonary lesions were analyzed. Univariate logistic regression was performed to assess for potential predictors of extra-pulmonary metastatic disease. The variables evaluated were age, gender, original and recurrent lesion size and imaging characteristics, recurrence location, presence of chest wall or mediastinal invasion, lymphadenopathy, and malignancy subtype. Results: 76 patients were included (33 males; mean age 70.9, standard deviation [SD] 7.7). The primary lesions were adenocarcinoma (N=50), squamous cell carcinoma (N=21), and other (N=5). The mean time to recurrence was 24.3 months (SD=18.8) from date of surgical excision. The two significant predictors of extra-pulmonary metastatic disease were: having >1 recurrent lesion (odds ratio [OR], 8.1; p=0.004), and the presence of suspicious lymphadenopathy at the time of recurrence (OR, 14.1; p<0.001).Conclusion: In lung cancer recurrence, the presence of >1 recurrent lesion and suspicious lymphadenopathy at the time of recurrence were significant predictors of extra-pulmonary metastatic disease. These findings may help guide the risk stratification and management of patients with recurrent lung cancer.